The CamSol method of rational design of protein mutants with enhanced solubility; A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity; MobiDB 3.0: more annotations for intrinsic disorder, conformational diversity and interactions in proteins; Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms; Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method; Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins; Parapred: antibody paratope prediction using convolutional and recurrent neural networks; Simultaneous quantification of protein order and disorder; Rapid and accurate in silico solubility screening of a monoclonal antibody library; Proteome-wide observation of the phenomenon of life on the edge of solubility; Third generation antibody discovery methods: in silico rational design; A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease; The s2D method: simultaneous sequence-based prediction of the statistical populations of ordered and disordered regions in proteins; Targeting disordered proteins with small molecules using entropy; In vitro and in silico assessment of the developability of a designed monoclonal antibody library; Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity; Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases; Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability; Rational design of a conformation-specific antibody for the quantification of Aβ oligomers; Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery
